Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

By Müller-Lissner Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 391-401

Informa Healthcare

Access to resources Recommend Favorite

Effect of tachykinin receptor antagonists in experimental neuropathic pain

By Coudore-Civiale M.-A.   Courteix C.   Eschalier A.   Fialip J.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 175-184

Elsevier

Access to resources Recommend Favorite

NMDA Antagonists and Neuropathic Pain - Multiple Drug Targets and Multiple Uses

By  

Current Pharmaceutical Design, Vol. 11, Iss. 23, 2005-09 ,pp. : 2977-2994

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Sigma-1 (sig1) Receptor Antagonists: Emerging Target for the Treatment of Neuropathic Pain

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 172-183

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecules Targeting the NMDA Receptor Complex as Drugs for Neuropathic Pain

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-11 ,pp. : 749-756

Bentham Science Publishers

Access to resources Recommend Favorite